EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Infantile-Onset Glutaric Acidemia Type I with Mild Hepatopathy: Clinical, Biochemical, and Molecular Characterization of an Iranian Pediatric Cohort

Zahra Beyzaei, Bita Geramizadeh, Seyed Mohsen Dehghani, Sorour Inaloo, Ralf Weiskirchen iD

Genes · 18.04.2026 · 17 (4) · 481

DOI: 10.3390/genes17040481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 18.04.2026. Verfasst von Zahra Beyzaei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Research Center, Shiraz University of Medical Sciences, Shiraz 7193711351, Iran. Hauptthemen laut MEDLINE: Glutaryl-CoA Dehydrogenase, Brain Diseases, Metabolic, Amino Acid Metabolism, Inborn Errors, Liver Diseases. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glutaric acidemia type 1 (GA1) is an autosomal recessive neurometabolic disorder caused by pathogenic variants in glutaryl-CoA dehydrogenase (GCDH), with variable clinical severity despite early biochemical detectability. Population-specific mutational spectra and genotype–phenotype correlations remain insufficiently defined in infantile-onset disease. Therefore, this study aimed to define the GCDH variant spectrum in GA1 patients with mild hepatopathy and assess genotype–phenotype correlations.

Methods

We performed integrated clinical, biochemical, and molecular characterization of 15 unrelated patients with infantile-onset GA1. Whole-exome sequencing (WES) was performed for all participants, and the resulting data were compared with the reference sequence of the GCDH gene.

Results

All patients presented within the first 6 months of life with macrocephaly, seizures, dystonia, and feeding difficulties. Neurological impairment and mild hepatopathy were variably observed, and one patient developed an acute encephalopathic crisis. Six homozygous GCDH variants were identified, predominantly missense. A common variant, c.541G>C (p.Glu181Gln), accounted for 73.3% of cases and defined a consistent phenotype of early macrocephaly and movement disorder with frequent mild hepatic involvement, suggesting regional enrichment and raising the possibility of a founder effect that warrants confirmation in future haplotype studies. A truncating variant, c.382C>T (p.Arg128Ter), was associated with severe early encephalopathy. Exon 6 represented a mutational hotspot. Biochemically, all patients showed elevated urinary glutaric and 3-hydroxyglutaric acids, increased glutarylcarnitine, and low-to-normal free carnitine, with higher metabolite levels in clinically more severe cases. All variants were pathogenic or likely pathogenic and extremely rare in population databases.

Conclusions

This cohort reveals a striking predominance of the GCDH c.541G>C variant and establishes a clear biochemical signature with genotype-associated clinical patterns in infantile-onset GA1. These findings support a population-specific mutational spectrum, refine genotype–phenotype correlations, and underscore the importance of early molecular diagnosis to guide targeted neurological and hepatic monitoring as well as regional screening strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutaryl-CoA DehydrogenaseBrain Diseases, MetabolicAmino Acid Metabolism, Inborn ErrorsLiver DiseasesHumansFemaleInfantMaleIranPhenotypeExome SequencingMutationGenetic Association StudiesGlutarates

Stichwörter der Autor:innen

GCDHgenotype–phenotype correlationglutaric acidemia type Imild hepatopathyorganic acidemiapediatric metabolic disease

Substanzen

Glutaryl-CoA DehydrogenaseGlutarates

Autor:innen und Institutionen

  • Transplant Research Center, Shiraz University of Medical Sciences, Shiraz 7193711351, Iran.
  • Gastroenterology and Hepatology Research Center, Shiraz University of Medical Sciences, Shiraz 7193711351, Iran.
  • Neuroscience Research Centers, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.

ORCID-Profile: Ralf Weiskirchen

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Beyzaei, Z., Geramizadeh, B., Dehghani, S. M., Inaloo, S., & Weiskirchen, R. (2026). Infantile-Onset Glutaric Acidemia Type I with Mild Hepatopathy: Clinical, Biochemical, and Molecular Characterization of an Iranian Pediatric Cohort. Genes, 17(4), 481. https://doi.org/10.3390/genes17040481

Vancouver

Beyzaei Z, Geramizadeh B, Dehghani SM, Inaloo S, Weiskirchen R. Infantile-Onset Glutaric Acidemia Type I with Mild Hepatopathy: Clinical, Biochemical, and Molecular Characterization of an Iranian Pediatric Cohort. Genes. 2026;17(4):481. doi:10.3390/genes17040481

BibTeX
@article{Beyzaei2026,
  author = {Beyzaei, Zahra and Geramizadeh, Bita and Dehghani, Seyed Mohsen and Inaloo, Sorour and Weiskirchen, Ralf},
  title = {Infantile-Onset Glutaric Acidemia Type I with Mild Hepatopathy: Clinical, Biochemical, and Molecular Characterization of an Iranian Pediatric Cohort},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {481},
  doi = {10.3390/genes17040481}
}
Kostenlos starten →